Qube Research & Technologies (QRT)
AGN

Qube Research & Technologies (QRT)’s Allergan plc AGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,082
Closed -$1.79M – 2113
2020
Q1 		$1.79M Buy
10,082
+143
+1% +$26.9K 0.07% 254
2019
Q4 		$1.9M Buy
+9,939
New +$1.79M 0.06% 379
2019
Q2 		– Sell
-12,049
Closed -$1.76M – 602
2019
Q1 		$1.76M Buy
12,049
+7,814
+185% +$1.13M 0.23% 108
2018
Q4 		$566K Buy
4,235
+918
+28% +$150K 0.24% 102
2018
Q3 		$632K Buy
3,317
+895
+37% +$164K 0.08% 180
2018
Q2 		$404K Buy
+2,422
New +$389K 0.25% 81

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AGN Position: Q2 2020 in Review

Qube Research & Technologies (QRT) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 10,082 shares — an estimated $1.79M sold.

Qube Research & Technologies (QRT) first reported a position in AGN in Q2 2018 and held it in 6 quarters. The position peaked at $1.9M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Qube Research & Technologies (QRT) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 10,082 Allergan plc shares in Q2 2020, an estimated $1.79M.
  • Qube Research & Technologies (QRT) first reported a position in Allergan plc in Q2 2018 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Allergan plc position peaked at $1.9M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2020, filed 14 Aug 2020.